skip to main content
Idioma:
Refinado por: Nome da Publicação: Critical Care Medicine remover assunto: Sepsis - Drug Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program

Ferrer, Ricard ; Martin-Loeches, Ignacio ; Phillips, Gary ; Osborn, Tiffany M ; Townsend, Sean ; Dellinger, R Phillip ; Artigas, Antonio ; Schorr, Christa ; Levy, Mitchell M

Critical care medicine, 2014-08, Vol.42 (8), p.1749-1755 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
2
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment

Vincent, Jean-Louis ; Bernard, Gordon R ; Beale, Richard ; Doig, Christopher ; Putensen, Christian ; Dhainaut, Jean-Francois ; Artigas, Antonio ; Fumagalli, Roberto ; Macias, William ; Wright, Theressa ; Wong, Kar ; Sundin, David P ; Turlo, Mary Ann ; Janes, Jonathan

Critical care medicine, 2005-10, Vol.33 (10), p.2266-2277 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
3
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial

Vincent, Jean-Louis ; Marshall, John C ; Dellinger, R Phillip ; Simonson, Steven G ; Guntupalli, Kalpalatha ; Levy, Mitchell M ; Singer, Mervyn ; Malik, Rajesh

Critical care medicine, 2015-09, Vol.43 (9), p.1832-1838 [Periódico revisado por pares]

United States: Copyright by by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc

Texto completo disponível

Citações Citado por
4
Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis
Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: The role of activated protein C in severe sepsis

Bernard, Gordon ; Artigas, Antonio ; Dellinger, Philip ; Esmon, Charles ; Faist, Eugen ; Faust, Saul N ; Fisher, Charles J ; Fumagalli, Roberto ; Grinnell, Brian W ; Sprung, Charles

Critical care medicine, 2001-07, Vol.29 (7 Suppl 1), p.S75-S77 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.